A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation
Clinical trial NCT02834936 · COMPLETED
Trial details
- NCT number
- NCT02834936
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-20
- Primary completion
- 2019-06-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.